G9092

HCPCS

Onc dx rectal t1-3,n1-2noprg

Official HCPCS Level II long descriptor

Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-3, n1-2, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence or metastases (for use in a medicare-approved demonstration project)

HCPCS Level II code G9092 is maintained by CMS and is active in the current quarterly release.

Short descriptor

Onc dx rectal t1-3,n1-2noprg

Added to HCPCS: 2006-01-01

Nearby codes in G9

Where this code sits

HCPCS Level II G9 codes

Krasyn Codes for Chrome

Review coding suggestions beside a validated web workflow. Private pilot.

Request pilot access

Source

HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.

Review coding suggestions beside your workflow. Krasyn Codes for Chrome is in a private pilot.Request pilot access →